首页 > 最新文献

Journal of Obesity最新文献

英文 中文
10-Year Weight Gain in 13,802 US Adults: The Role of Age, Sex, and Race. 13802名美国成年人10年体重增加:年龄、性别和种族的作用
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-05-06 eCollection Date: 2022-01-01 DOI: 10.1155/2022/7652408
Larry A Tucker, Kayla Parker

Purpose: The primary objective of the present investigation was to identify 10-year weight gain patterns in 13,802 US adults and also to determine the extent that differences in 10-year weight gains were associated with the key demographic variables: age, sex, and race.

Methods: The study design was cross-sectional and included the years 2011-2018. Data for 2019-2020 were not available because of COVID. A multistage random sampling strategy was employed. Specifically, individual sample weights and randomly selected clusters and strata were used with each statistical model, allowing the results to be generalized to the US adult population.

Results: Mean (±SE) 10-year weight gain was 4.2 ± 0.2 kg or 6.6 ± 0.2% of initial body weight. A total of 51% of the participants gained 5% or more body weight, 36% gained 10% or more, and 16% gained 20% or more across the 10-years. Age was linearly and inversely associated with 10-year weight gain, expressed in kg (F = 166.4, P < 0.0001) or percent weight gain (F = 246.9, P < 0.0001), after adjusting for sex and race. For each 1-year increase in age, 10-year weight gain decreased by 0.20 ± 0.02 kg and 0.28 ± 0.02 percent. After adjusting for age and race, 10-year weight gain (kg) was significantly greater (F = 73.6, P < 0.0001) in women (5.4 ± 0.3) than in men (2.6 ± 0.2). Weight gain also differed across races, kg (F = 27.7, P < 0.0001) and % (F = 28.5, P < 0.0001). Non-Hispanic Blacks gained more weight and NH Asians gained less weight than the other races.

Conclusion: Without question, 10-year weight gain is a serious problem within the US adult population. Younger adults, women, and Non-Hispanic Blacks, particularly Black women, seem to experience the highest levels of 10-year weight gain. Consequently, obesity and weight gain prevention programs focusing on these at-risk individuals should be a public health priority.

目的本研究的主要目的是确定13802名美国成年人的10年体重增加模式,并确定10年体重增长的差异与关键人口统计学变量(年龄、性别和种族)的相关性。方法研究设计为横断面,包括2011-2018年。由于新冠肺炎,2019年至2020年的数据不可用。采用了多级随机抽样策略。具体而言,每个统计模型都使用了个体样本权重和随机选择的聚类和阶层,从而将结果推广到美国成年人群。结果10年平均(±SE)体重增加4.2 ± 0.2 kg或6.6 ± 初始体重的0.2%。在这10年里,共有51%的参与者体重增加了5%或更多,36%的参与者体重增长了10%或更多,16%的参与者体重增重了20%或更多。年龄与10年体重增加呈线性和负相关,单位为kg(F = 166.4,P<0.0001)或体重增加百分比(F = 246.9,P<0.0001)。年龄每增加1年,10年的体重增加就减少0.20 ± 0.02 kg和0.28 ± 0.02%。在对年龄和种族进行调整后,10年的体重增加(kg)明显更大(F = 73.6,P<0.0001)(5.4 ± 0.3)高于男性(2.6 ± 0.2)。不同种族的体重增加也有所不同,kg(F = 27.7,P<0.0001)和%(F = 28.5,P<0.0001)。与其他种族相比,非西班牙裔黑人的体重增加更多,而非西班牙裔亚洲人的体重增加更少。结论毫无疑问,在美国成年人群中,10年的体重增加是一个严重的问题。年轻人、女性和非西班牙裔黑人,尤其是黑人女性,似乎经历了最高水平的10年体重增加。因此,针对这些高危人群的肥胖和体重增加预防计划应该成为公共卫生的优先事项。
{"title":"10-Year Weight Gain in 13,802 US Adults: The Role of Age, Sex, and Race.","authors":"Larry A Tucker, Kayla Parker","doi":"10.1155/2022/7652408","DOIUrl":"10.1155/2022/7652408","url":null,"abstract":"<p><strong>Purpose: </strong>The primary objective of the present investigation was to identify 10-year weight gain patterns in 13,802 US adults and also to determine the extent that differences in 10-year weight gains were associated with the key demographic variables: age, sex, and race.</p><p><strong>Methods: </strong>The study design was cross-sectional and included the years 2011-2018. Data for 2019-2020 were not available because of COVID. A multistage random sampling strategy was employed. Specifically, individual sample weights and randomly selected clusters and strata were used with each statistical model, allowing the results to be generalized to the US adult population.</p><p><strong>Results: </strong>Mean (±SE) 10-year weight gain was 4.2 ± 0.2 kg or 6.6 ± 0.2% of initial body weight. A total of 51% of the participants gained 5% or more body weight, 36% gained 10% or more, and 16% gained 20% or more across the 10-years. Age was linearly and inversely associated with 10-year weight gain, expressed in kg (<i>F</i> = 166.4, <i>P</i> < 0.0001) or percent weight gain (<i>F</i> = 246.9, <i>P</i> < 0.0001), after adjusting for sex and race. For each 1-year increase in age, 10-year weight gain decreased by 0.20 ± 0.02 kg and 0.28 ± 0.02 percent. After adjusting for age and race, 10-year weight gain (kg) was significantly greater (<i>F</i> = 73.6, <i>P</i> < 0.0001) in women (5.4 ± 0.3) than in men (2.6 ± 0.2). Weight gain also differed across races, kg (<i>F</i> = 27.7, <i>P</i> < 0.0001) and % (<i>F</i> = 28.5, <i>P</i> < 0.0001). Non-Hispanic Blacks gained more weight and NH Asians gained less weight than the other races.</p><p><strong>Conclusion: </strong>Without question, 10-year weight gain is a serious problem within the US adult population. Younger adults, women, and Non-Hispanic Blacks, particularly Black women, seem to experience the highest levels of 10-year weight gain. Consequently, obesity and weight gain prevention programs focusing on these at-risk individuals should be a public health priority.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2022-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41360479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Effect of P-Cymene on Lipid Profile, Liver Enzyme, and Akt/Mtor Pathway in Streptozotocin-Induced Diabetes Mellitus in Wistar Rats 对-Cymene对链脲佐菌素诱导的Wistar大鼠糖尿病脂质、肝酶和Akt/Mtor通路的治疗作用
IF 3.3 Q1 Medicine Pub Date : 2022-04-26 DOI: 10.1155/2022/1015669
Maryam Arabloei Sani, P. Yaghmaei, Z. Hajebrahimi, N. Hayati Roodbari
Diabetes is a serious public health problem in low- and middle-income countries. There is a strong link between hyperglycemia, oxidative stress, inflammation, and the development of diabetes mellitus. PI3K/Akt/mTOR is the main signaling pathway of insulin for controlling lipid and glucose metabolism. P-cymene is an aromatic monoterpene with a widespread range of therapeutic properties including antioxidant and anti-inflammatory activity. In the present study, the antidiabetic effects of p-cymene were investigated. Diabetes was induced using streptozotocin in male Wistar rats. The effects of p-cymene and metformin were studied on levels of glucose (Glu), lipid profile, liver enzymes, oxidative stress, and the expression of Akt, phospho-Akt, and mTOR (mammalian target of rapamycin) proteins, using biochemical, histological, and immunohistochemical analysis. Data have shown that p-cymene can improve serum levels of Glu, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), malondialdehyde (MDA), and the expression of mTOR, Akt, and phospho-Akt protein in diabetic animals. These results suggest that p-cymene has hypoglycemia, hypolipidemia, and antioxidant properties. It can regulate Akt/mTOR pathway and reduce hepatic and pancreas injury. It can be suggested for diabetes management alone or simultaneously with metformin.
糖尿病在低收入和中等收入国家是一个严重的公共卫生问题。高血糖、氧化应激、炎症和糖尿病的发展之间有着密切的联系。PI3K/Akt/mTOR是胰岛素控制脂糖代谢的主要信号通路。对伞花烯是一种芳香单萜,具有广泛的抗氧化和抗炎活性。本文研究了对伞花烃的抗糖尿病作用。用链脲佐菌素诱导雄性Wistar大鼠患糖尿病。通过生化、组织学和免疫组织化学分析,研究了对花茉莉烯和二甲双胍对小鼠葡萄糖(Glu)、血脂、肝酶、氧化应激水平以及Akt、磷酸化Akt和mTOR(哺乳动物雷帕霉素靶蛋白)蛋白表达的影响。有数据表明,对花香烃能提高糖尿病动物血清Glu、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-c)、低密度脂蛋白(LDL)、极低密度脂蛋白(VLDL)、碱性磷酸酶(ALP)、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、丙二醛(MDA)水平,以及mTOR、Akt、phospho-Akt蛋白的表达。这些结果表明,对伞花烃具有降血糖、降血脂和抗氧化的特性。可调节Akt/mTOR通路,减轻肝、胰腺损伤。可建议单独或同时与二甲双胍治疗糖尿病。
{"title":"Therapeutic Effect of P-Cymene on Lipid Profile, Liver Enzyme, and Akt/Mtor Pathway in Streptozotocin-Induced Diabetes Mellitus in Wistar Rats","authors":"Maryam Arabloei Sani, P. Yaghmaei, Z. Hajebrahimi, N. Hayati Roodbari","doi":"10.1155/2022/1015669","DOIUrl":"https://doi.org/10.1155/2022/1015669","url":null,"abstract":"Diabetes is a serious public health problem in low- and middle-income countries. There is a strong link between hyperglycemia, oxidative stress, inflammation, and the development of diabetes mellitus. PI3K/Akt/mTOR is the main signaling pathway of insulin for controlling lipid and glucose metabolism. P-cymene is an aromatic monoterpene with a widespread range of therapeutic properties including antioxidant and anti-inflammatory activity. In the present study, the antidiabetic effects of p-cymene were investigated. Diabetes was induced using streptozotocin in male Wistar rats. The effects of p-cymene and metformin were studied on levels of glucose (Glu), lipid profile, liver enzymes, oxidative stress, and the expression of Akt, phospho-Akt, and mTOR (mammalian target of rapamycin) proteins, using biochemical, histological, and immunohistochemical analysis. Data have shown that p-cymene can improve serum levels of Glu, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), malondialdehyde (MDA), and the expression of mTOR, Akt, and phospho-Akt protein in diabetic animals. These results suggest that p-cymene has hypoglycemia, hypolipidemia, and antioxidant properties. It can regulate Akt/mTOR pathway and reduce hepatic and pancreas injury. It can be suggested for diabetes management alone or simultaneously with metformin.","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44879496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Connections between Children's Eating Habits, Mental Health, and Parental Stress. 儿童饮食习惯、心理健康与父母压力之间的关系
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-04-12 eCollection Date: 2022-01-01 DOI: 10.1155/2022/6728502
Marco Tommasi, Francesca Toro, Alessandra Salvia, Aristide Saggino

Background: Obesity and eating disorders are increasing in occidental countries and can undermine physical and psychological health. Therefore, preventing the insurgency of unhealthy eating habits in childhood is fundamental. Parents can play an important role in assisting pediatricians, psychiatrists, and clinical psychologists in the diagnosis of eating disorders because they have an active role in observing and assessing the quality of their children's eating habits.

Methods: In our study, we collected data from a sample of children (n = 125) and their parents (n = 161) without symptoms related to eating disorders. Parents assessed the eating habits, behavior problems, and mental health of their children and parental stress. In addition, we measured body mass index, anxiety, and lifestyle in children. Data were analyzed with bivariate correlation and MIMIC models.

Results: Both mothers' and fathers' assessments of children's eating habits are reliable. Unhealthy eating habits are connected with children's behavioral problems and parental stress. We did not find significant differences in feeding styles and ways of assessing the quality of eating habits between mothers and fathers. Our study showed greater sensitivity of mothers toward the physical fitness of their children rather than fathers.

Conclusions: Mothers and fathers both proved to be good observers of their children's eating behavior, and they could cooperate with medical and psychological operators in preventing the risk of obesity.

背景肥胖和饮食失调在西方国家日益增加,并可能损害身体和心理健康。因此,防止儿童时期不健康饮食习惯的反叛是至关重要的。父母可以在协助儿科医生、精神科医生和临床心理学家诊断饮食障碍方面发挥重要作用,因为他们在观察和评估孩子的饮食习惯质量方面发挥着积极作用。方法本研究以儿童(n = 125)及其父母(n = 161),没有与饮食失调有关的症状。父母评估了孩子的饮食习惯、行为问题、心理健康和父母的压力。此外,我们还测量了儿童的体重指数、焦虑和生活方式。数据采用双变量相关和MIMIC模型进行分析。结果父母对儿童饮食习惯的评价都是可靠的。不健康的饮食习惯与孩子的行为问题和父母的压力有关。我们没有发现母亲和父亲在喂养方式和评估饮食习惯质量的方法方面存在显著差异。我们的研究表明,母亲对孩子的身体健康比父亲更敏感。结论母亲和父亲都能很好地观察孩子的饮食行为,并能与医疗和心理工作者合作预防肥胖风险。
{"title":"Connections between Children's Eating Habits, Mental Health, and Parental Stress.","authors":"Marco Tommasi, Francesca Toro, Alessandra Salvia, Aristide Saggino","doi":"10.1155/2022/6728502","DOIUrl":"10.1155/2022/6728502","url":null,"abstract":"<p><strong>Background: </strong>Obesity and eating disorders are increasing in occidental countries and can undermine physical and psychological health. Therefore, preventing the insurgency of unhealthy eating habits in childhood is fundamental. Parents can play an important role in assisting pediatricians, psychiatrists, and clinical psychologists in the diagnosis of eating disorders because they have an active role in observing and assessing the quality of their children's eating habits.</p><p><strong>Methods: </strong>In our study, we collected data from a sample of children (<i>n</i> = 125) and their parents (<i>n</i> = 161) without symptoms related to eating disorders. Parents assessed the eating habits, behavior problems, and mental health of their children and parental stress. In addition, we measured body mass index, anxiety, and lifestyle in children. Data were analyzed with bivariate correlation and MIMIC models.</p><p><strong>Results: </strong>Both mothers' and fathers' assessments of children's eating habits are reliable. Unhealthy eating habits are connected with children's behavioral problems and parental stress. We did not find significant differences in feeding styles and ways of assessing the quality of eating habits between mothers and fathers. Our study showed greater sensitivity of mothers toward the physical fitness of their children rather than fathers.</p><p><strong>Conclusions: </strong>Mothers and fathers both proved to be good observers of their children's eating behavior, and they could cooperate with medical and psychological operators in preventing the risk of obesity.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2022-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45594560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Anthropometric Indices with Menstrual Abnormality among Nursing Students of Nepal: A Cross-Sectional Study 尼泊尔护生人体测量指标与月经异常的关系:一项横断面研究
IF 3.3 Q1 Medicine Pub Date : 2022-03-18 DOI: 10.1155/2022/6755436
K. Amgain, Prativa Subedi, G. Yadav, Sujana Neupane, S. Khadka, S. Sapkota
Introduction Obesity has been reported to be linked with menstrual abnormalities including abnormality in cycle length, duration, and period blood loss. However, which anthropometric parameter is a better marker of menstrual abnormality is yet unknown. This study aims to explore the association of BMI, waist-hip ratio (WHR), and waist-height ratio (WHtR) with menstrual abnormalities. Methods This was a cross-sectional study conducted among 240 nursing students on two nursing campuses of Nepal. Demographic and menstrual characteristics related data were collected from the participants via the face-to-face interview technique followed by anthropometric measurements. Binary logistic regression was used to study the association of BMI, WHR, and WHtR with menstrual characteristics. Univariable and multivariable regression models were calculated at 95% confidence interval and a P value of 0.05 using a Statistical Package for Social Sciences, IBM SPSS® v21 (IBM, Armonk, New York). Results Out of 240 participants, 52 participants (21.67%) were underweight (<18.5 kg/m2), and 47 participants (19.58%) were either overweight (≥23 kg/m2) or obese (≥25 kg/m2). Overweight and obese BMI was associated with abnormality in menstrual cycle length (AOR = 4.24; 95% CI = 1.77–10.17), duration of the menstrual period (AOR = 2.52; 95% CI = 1.09–5.81), and periodic menstrual blood loss (AOR = 9.04; 95% CI = 3.55–23.01). Increase in WHtR (>0.5) was associated with abnormal cycle length (AOR = 3.09; 95% CI = 1.09–8.80) and abnormal period duration (AOR = 3.05; 95% CI = 1.10–8.44). An increase in WHR (>0.8) was associated with abnormal cyclical menstrual blood loss (AOR = 4.93; 95% CI = 1.55–15.71). Conclusions Obesity predisposes to menstrual irregularities. BMI is a better predictor of menstrual irregularity as the increase in BMI is associated with abnormality in menstrual cycle length, period duration, and blood loss. Increased WHR was associated with periodic blood loss only. Increased WHtR was associated with abnormal cycle length and period duration, but not menstrual blood loss.
据报道,肥胖与月经异常有关,包括月经周期长度、持续时间和月经失血异常。然而,哪个人体测量参数是一个更好的月经异常的标志尚不清楚。本研究旨在探讨BMI、腰臀比(WHR)、腰高比(WHtR)与月经异常的关系。方法采用横断面研究方法,对尼泊尔两所护理学院的240名护生进行调查。通过面对面访谈技术收集参与者的人口统计学和月经特征相关数据,然后进行人体测量。采用二元logistic回归研究BMI、腰臀比和腰臀比与月经特征的关系。单变量和多变量回归模型采用IBM SPSS®v21 (IBM, Armonk, New York)社会科学统计软件包,以95%置信区间和P值0.05计算。结果240名受试者中,52名(21.67%)体重不足(0.5)与异常周期长度相关(AOR = 3.09;95% CI = 1.09-8.80)和异常期持续时间(AOR = 3.05;95% ci = 1.10-8.44)。WHR升高(>.8)与异常周期性月经失血量相关(AOR = 4.93;95% ci = 1.55-15.71)。结论肥胖易导致月经不规律。BMI是一个更好的预测月经不规律的指标,因为BMI的增加与月经周期长度、经期持续时间和失血异常有关。腰宽比增加仅与周期性失血有关。WHtR增加与异常周期长度和月经持续时间有关,但与月经出血量无关。
{"title":"Association of Anthropometric Indices with Menstrual Abnormality among Nursing Students of Nepal: A Cross-Sectional Study","authors":"K. Amgain, Prativa Subedi, G. Yadav, Sujana Neupane, S. Khadka, S. Sapkota","doi":"10.1155/2022/6755436","DOIUrl":"https://doi.org/10.1155/2022/6755436","url":null,"abstract":"Introduction Obesity has been reported to be linked with menstrual abnormalities including abnormality in cycle length, duration, and period blood loss. However, which anthropometric parameter is a better marker of menstrual abnormality is yet unknown. This study aims to explore the association of BMI, waist-hip ratio (WHR), and waist-height ratio (WHtR) with menstrual abnormalities. Methods This was a cross-sectional study conducted among 240 nursing students on two nursing campuses of Nepal. Demographic and menstrual characteristics related data were collected from the participants via the face-to-face interview technique followed by anthropometric measurements. Binary logistic regression was used to study the association of BMI, WHR, and WHtR with menstrual characteristics. Univariable and multivariable regression models were calculated at 95% confidence interval and a P value of 0.05 using a Statistical Package for Social Sciences, IBM SPSS® v21 (IBM, Armonk, New York). Results Out of 240 participants, 52 participants (21.67%) were underweight (<18.5 kg/m2), and 47 participants (19.58%) were either overweight (≥23 kg/m2) or obese (≥25 kg/m2). Overweight and obese BMI was associated with abnormality in menstrual cycle length (AOR = 4.24; 95% CI = 1.77–10.17), duration of the menstrual period (AOR = 2.52; 95% CI = 1.09–5.81), and periodic menstrual blood loss (AOR = 9.04; 95% CI = 3.55–23.01). Increase in WHtR (>0.5) was associated with abnormal cycle length (AOR = 3.09; 95% CI = 1.09–8.80) and abnormal period duration (AOR = 3.05; 95% CI = 1.10–8.44). An increase in WHR (>0.8) was associated with abnormal cyclical menstrual blood loss (AOR = 4.93; 95% CI = 1.55–15.71). Conclusions Obesity predisposes to menstrual irregularities. BMI is a better predictor of menstrual irregularity as the increase in BMI is associated with abnormality in menstrual cycle length, period duration, and blood loss. Increased WHR was associated with periodic blood loss only. Increased WHtR was associated with abnormal cycle length and period duration, but not menstrual blood loss.","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2022-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47308006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Prevalence of Obesity and Overweight among Adults in the Middle East Countries from 2000 to 2020: A Systematic Review and Meta-Analysis. 2000年至2020年中东国家成人肥胖和超重患病率:系统回顾和荟萃分析
IF 3.3 Q1 Medicine Pub Date : 2022-02-03 eCollection Date: 2022-01-01 DOI: 10.1155/2022/8074837
Hassan Okati-Aliabad, Alireza Ansari-Moghaddam, Shiva Kargar, Neda Jabbari

Background: Obesity has become a significant public health issue worldwide, and it is a major risk factor for many noncommunicable diseases. This systematic review aimed to identify the prevalence of obesity and overweight in the Middle East region and different countries in this region.

Materials and methods: PubMed, Google Scholar, and MEDLINE databases were searched from 2000-2020 to identify relevant studies in the Middle East area. The survey was carried out using combinations of Medical Subject Headings (Mesh) keywords like "body mass index", "obesity", "overweight", "prevalence", "Middle-East", and "Countries in the Middle East area". Analysis of the data was done using STATA-14, and a random-effects model was used to estimate the pooled prevalence.

Results: A total of 101 studies with 698905 participants have been identified that met inclusion criteria for this meta-analysis. The pooled estimates of the prevalence of obesity and overweight in the Middle East area were 21.17 (95% CI: 17.05-26.29) and 33.14 (95% CI: 26.87-40.87), respectively. The findings showed that obesity prevalence increased with age so that the highest prevalence of obesity and overweight was observed in people >40 years old. Obesity prevalence in the Middle East area remained steady between 2000-2006 and 2014-2020 (23%). During these time intervals, the prevalence of overweight decreased from 34.83 (95% CI: 32.40-37.45) to 32.85 (95% CI: 31.39-34.38).

Conclusions: Despite the relative stabilization of the overweight and obesity trend in the Middle East, current interventions to combat the overweight epidemic need to be maintained and strengthened because the prevalence of overweight and obesity in this region is still very high. The prevalence of obesity increases with age so that people over 40 have the highest percentage of obesity and overweight. Therefore, implementing intervention programs to prevent and control obesity and overweight in the Middle East is essential.

背景:肥胖已成为世界范围内一个重要的公共卫生问题,是许多非传染性疾病的主要危险因素。本系统综述旨在确定中东地区和该地区不同国家的肥胖和超重患病率。材料和方法:检索PubMed、Google Scholar和MEDLINE数据库,检索2000-2020年中东地区的相关研究。该调查使用了诸如“身体质量指数”、“肥胖”、“超重”、“患病率”、“中东”和“中东地区国家”等医学主题词(Mesh)的组合进行。使用STATA-14对数据进行分析,并使用随机效应模型来估计合并患病率。结果:共有101项研究698905名受试者符合本荟萃分析的纳入标准。中东地区肥胖和超重患病率的汇总估计分别为21.17 (95% CI: 17.05-26.29)和33.14 (95% CI: 26.87-40.87)。研究结果表明,肥胖患病率随着年龄的增长而增加,其中40岁以上的人群肥胖和超重患病率最高。中东地区的肥胖患病率在2000-2006年和2014-2020年期间保持稳定(23%)。在这些时间间隔内,超重患病率从34.83 (95% CI: 32.40-37.45)降至32.85 (95% CI: 31.39-34.38)。结论:尽管中东地区的超重和肥胖趋势相对稳定,但由于该地区的超重和肥胖患病率仍然很高,因此需要维持和加强目前对抗超重流行病的干预措施。肥胖的患病率随着年龄的增长而增加,因此40岁以上的人肥胖和超重的比例最高。因此,在中东地区实施预防和控制肥胖和超重的干预方案至关重要。
{"title":"Prevalence of Obesity and Overweight among Adults in the Middle East Countries from 2000 to 2020: A Systematic Review and Meta-Analysis.","authors":"Hassan Okati-Aliabad,&nbsp;Alireza Ansari-Moghaddam,&nbsp;Shiva Kargar,&nbsp;Neda Jabbari","doi":"10.1155/2022/8074837","DOIUrl":"https://doi.org/10.1155/2022/8074837","url":null,"abstract":"<p><strong>Background: </strong>Obesity has become a significant public health issue worldwide, and it is a major risk factor for many noncommunicable diseases. This systematic review aimed to identify the prevalence of obesity and overweight in the Middle East region and different countries in this region.</p><p><strong>Materials and methods: </strong>PubMed, Google Scholar, and MEDLINE databases were searched from 2000-2020 to identify relevant studies in the Middle East area. The survey was carried out using combinations of Medical Subject Headings (Mesh) keywords like \"body mass index\", \"obesity\", \"overweight\", \"prevalence\", \"Middle-East\", and \"Countries in the Middle East area\". Analysis of the data was done using STATA-14, and a random-effects model was used to estimate the pooled prevalence.</p><p><strong>Results: </strong>A total of 101 studies with 698905 participants have been identified that met inclusion criteria for this meta-analysis. The pooled estimates of the prevalence of obesity and overweight in the Middle East area were 21.17 (95% CI: 17.05-26.29) and 33.14 (95% CI: 26.87-40.87), respectively. The findings showed that obesity prevalence increased with age so that the highest prevalence of obesity and overweight was observed in people >40 years old. Obesity prevalence in the Middle East area remained steady between 2000-2006 and 2014-2020 (23%). During these time intervals, the prevalence of overweight decreased from 34.83 (95% CI: 32.40-37.45) to 32.85 (95% CI: 31.39-34.38).</p><p><strong>Conclusions: </strong>Despite the relative stabilization of the overweight and obesity trend in the Middle East, current interventions to combat the overweight epidemic need to be maintained and strengthened because the prevalence of overweight and obesity in this region is still very high. The prevalence of obesity increases with age so that people over 40 have the highest percentage of obesity and overweight. Therefore, implementing intervention programs to prevent and control obesity and overweight in the Middle East is essential.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2022-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39915405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 46
Age-Related Trends in Body Composition among Women Aged 20-80 Years: A Cross-Sectional Study. 20-80岁女性身体成分的年龄相关趋势:一项横断面研究
IF 3.3 Q1 Medicine Pub Date : 2022-02-02 eCollection Date: 2022-01-01 DOI: 10.1155/2022/4767793
Nirmala Rathnayake, Hasanga Rathnayake, Sarath Lekamwasam

The determinants of body composition are likely to vary geographically due to the diversity of genetic and environmental factors between populations. Age-related trends in body composition in a population help understanding the health issues that are linked with different body compartments. In general, such studies are scarce in the South Asian region and this cross-sectional study examined the age-related trends in body composition in a selected group of healthy women aged 20-80 years in Sri Lanka. The study included randomly selected 784 healthy women aged 20-80 years from the Southern province, Sri Lanka. Women were divided into five age groups: 20-29 years (n = 79), 30-39 years (n = 144), 40-49 years (n = 185), 50-59 years (n = 281), and ≥60 years (n = 85). Total body bone mineral density (TBBMD, g/cm2), total body bone mineral content (TBBMC, g), total body fat mass (TBFM, kg), and total body lean mass (TBLM, kg) were measured with central-type dual-energy X-ray absorptiometry (DXA). Multivariate analysis of variance with Bonferroni post hoc test was performed. The age-related trends of TBBMD and TBBMC were similar with a peak in 40-49-year age group. Between 50 and 59 and ≥60 age categories, TBBMD and TBBMC showed a rapid decline: 16% and 23%, respectively. The rate of TBBMD decline was 0.008 g/cm2 per year after 50 years. TBFM increased by 14% between age categories 20-29 and 40-49 years and remained unchanged after 49 years. TBLM increased by 15% between age groups 20-29 and 40-49 years and then decreased by 13% between age categories 50-59 and ≥60 years. Of the 13% decrease in TBLM after 50 years, 9% loss occurred after 59 years. The trends observed help to understand the occurrence of diseases linked with body composition.

由于种群间遗传和环境因素的多样性,身体组成的决定因素可能在地理上有所不同。人群中与年龄相关的身体组成趋势有助于了解与不同身体部位相关的健康问题。总的来说,这类研究在南亚地区很少,本横断面研究调查了斯里兰卡一组20-80岁健康妇女的身体组成与年龄有关的趋势。该研究包括从斯里兰卡南部省份随机选择的784名年龄在20-80岁之间的健康女性。将女性分为5个年龄组:20-29岁(n = 79)、30-39岁(n = 144)、40-49岁(n = 185)、50-59岁(n = 281)和≥60岁(n = 85)。采用中心型双能x线骨密度仪(DXA)测量全身骨密度(TBBMD, g/cm2)、全身骨密度(TBBMC, g)、全身脂肪质量(TBFM, kg)、全身瘦质量(TBLM, kg)。采用Bonferroni事后检验进行多变量方差分析。TBBMD和TBBMC的年龄相关趋势相似,在40-49岁年龄组达到高峰。在50 ~ 59岁和≥60岁年龄组,TBBMD和TBBMC迅速下降,分别为16%和23%。50年后TBBMD下降速率为每年0.008 g/cm2。TBFM在20-29岁和40-49岁年龄组增加14%,49年后保持不变。TBLM在20-29岁和40-49岁年龄组中增加15%,在50-59岁和≥60岁年龄组中下降13%。50年后TBLM下降13%,59年后下降9%。观察到的趋势有助于了解与身体组成有关的疾病的发生。
{"title":"Age-Related Trends in Body Composition among Women Aged 20-80 Years: A Cross-Sectional Study.","authors":"Nirmala Rathnayake,&nbsp;Hasanga Rathnayake,&nbsp;Sarath Lekamwasam","doi":"10.1155/2022/4767793","DOIUrl":"https://doi.org/10.1155/2022/4767793","url":null,"abstract":"<p><p>The determinants of body composition are likely to vary geographically due to the diversity of genetic and environmental factors between populations. Age-related trends in body composition in a population help understanding the health issues that are linked with different body compartments. In general, such studies are scarce in the South Asian region and this cross-sectional study examined the age-related trends in body composition in a selected group of healthy women aged 20-80 years in Sri Lanka. The study included randomly selected 784 healthy women aged 20-80 years from the Southern province, Sri Lanka. Women were divided into five age groups: 20-29 years (<i>n</i> = 79), 30-39 years (<i>n</i> = 144), 40-49 years (<i>n</i> = 185), 50-59 years (<i>n</i> = 281), and ≥60 years (<i>n</i> = 85). Total body bone mineral density (TBBMD, g/cm<sup>2</sup>), total body bone mineral content (TBBMC, g), total body fat mass (TBFM, kg), and total body lean mass (TBLM, kg) were measured with central-type dual-energy X-ray absorptiometry (DXA). Multivariate analysis of variance with Bonferroni post hoc test was performed. The age-related trends of TBBMD and TBBMC were similar with a peak in 40-49-year age group. Between 50 and 59 and ≥60 age categories, TBBMD and TBBMC showed a rapid decline: 16% and 23%, respectively. The rate of TBBMD decline was 0.008 g/cm<sup>2</sup> per year after 50 years. TBFM increased by 14% between age categories 20-29 and 40-49 years and remained unchanged after 49 years. TBLM increased by 15% between age groups 20-29 and 40-49 years and then decreased by 13% between age categories 50-59 and ≥60 years. Of the 13% decrease in TBLM after 50 years, 9% loss occurred after 59 years. The trends observed help to understand the occurrence of diseases linked with body composition.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2022-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39791268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Laparoscopic Banded One Anastomosis Gastric Bypass: A Single-Center Series. 腹腔镜带状胃旁路吻合术:单中心系列。
IF 3.3 Q1 Medicine Pub Date : 2022-01-29 eCollection Date: 2022-01-01 DOI: 10.1155/2022/4942052
Michela Campanelli, Emanuela Bianciardi, Domenico Benavoli, Giulia Bagaglini, Giorgio Lisi, Paolo Gentileschi

Introduction: Laparoscopic one anastomosis gastric bypass (LOAGB) is a relatively new procedure for the treatment of morbid obesity and related comorbidities. On average, this procedure results in good postoperative weight loss with a low complication rate. Recent publications suggest that dumping syndrome and weight regain might be reduced by placing a silicone ring over the gastric pouch during the procedure, so called laparoscopic banded one anastomosis gastric bypass (LBOAGB).

Methods: 86 patients undergoing LBOAGB between 2018 and 2020 were enrolled in this retrospective study. Hospital records were used to assess weight loss, comorbidity resolution, and any complications either in the short or medium term.

Results: 54 Female and 32 male patients were included with a mean age of 43 years (25-64), preoperative body mass index of 42 kg/m2 (35-49), and preoperative weight of 114 kg (86-162). Thirty-four patients presented with type 2 diabetes (39.5%), 42 patients (49%) diagnosed with hypertension, 24 presented with OSAS (28%), and 21 (24%) hypercholesterolaemia patients were included. In total, 36 patients were diagnosed with multiple comorbidities. The operative data showed an average operative time of 48 minutes with 3.4% of patients suffering from early (minor) complications and 2.3% with a late (minor) complication. One patient required reoperation due to intra-abdominal bleeding. The median length of hospital stay was 2.5 days. Median follow-up was 18 months (5-36). In that period, no patient required ring removal or conversion to Roux-en-Y gastric bypass surgery. Food intolerance/vomiting was present in 1 patient (1.1%), bile reflux was present in 1 patient (1.1%), and no stomal ulcers were observed. Mean % excess weight loss at 12 and 24 months was 72% and 80%, respectively. Fifty-two out of 86 patients (60%) had a complete resolution of comorbidities. A CONUT score >2 (mild malnutrition) was found in 40% of patients, while a CONUT score 0-1 was found in 60% of patients.

Conclusion: LBOAGB shows promising results in terms of safety and efficacy in the short term. Further prospective studies will be required to evaluate the consistency of the results in the long term.

腹腔镜一次吻合胃旁路术(LOAGB)是治疗病态肥胖及相关合并症的一种相对较新的手术方法。平均而言,该手术的术后体重减轻效果良好,并发症发生率低。最近的出版物表明,通过在手术过程中在胃袋上放置硅胶环,即所谓的腹腔镜单吻合术胃旁路术(LBOAGB),可以减少倾倒综合征和体重反弹。方法:回顾性研究了2018 - 2020年间86例LBOAGB患者。使用医院记录来评估体重减轻、合并症的解决以及短期或中期的任何并发症。结果:女性54例,男性32例,平均年龄43岁(25-64岁),术前体重指数42 kg/m2(35-49),术前体重114 kg(86-162)。其中34例为2型糖尿病(39.5%),42例为高血压(49%),24例为OSAS(28%), 21例为高胆固醇血症(24%)。总共有36名患者被诊断患有多种合并症。手术资料显示平均手术时间为48分钟,3.4%的患者出现早期(轻微)并发症,2.3%的患者出现晚期(轻微)并发症。1例患者因腹内出血需要再次手术。住院时间中位数为2.5天。中位随访时间为18个月(5-36)。在此期间,没有患者需要取环或转Roux-en-Y胃旁路手术。1例(1.1%)患者出现食物不耐受/呕吐,1例(1.1%)患者出现胆汁反流,未观察到口溃疡。12个月和24个月的平均超重率分别为72%和80%。86例患者中有52例(60%)的合并症得到完全解决。40%的患者的CONUT评分>2(轻度营养不良),60%的患者的CONUT评分为0-1。结论:LBOAGB在短期内具有良好的安全性和有效性。需要进一步的前瞻性研究来评估长期结果的一致性。
{"title":"Laparoscopic Banded One Anastomosis Gastric Bypass: A Single-Center Series.","authors":"Michela Campanelli,&nbsp;Emanuela Bianciardi,&nbsp;Domenico Benavoli,&nbsp;Giulia Bagaglini,&nbsp;Giorgio Lisi,&nbsp;Paolo Gentileschi","doi":"10.1155/2022/4942052","DOIUrl":"https://doi.org/10.1155/2022/4942052","url":null,"abstract":"<p><strong>Introduction: </strong>Laparoscopic one anastomosis gastric bypass (LOAGB) is a relatively new procedure for the treatment of morbid obesity and related comorbidities. On average, this procedure results in good postoperative weight loss with a low complication rate. Recent publications suggest that dumping syndrome and weight regain might be reduced by placing a silicone ring over the gastric pouch during the procedure, so called laparoscopic banded one anastomosis gastric bypass (LBOAGB).</p><p><strong>Methods: </strong>86 patients undergoing LBOAGB between 2018 and 2020 were enrolled in this retrospective study. Hospital records were used to assess weight loss, comorbidity resolution, and any complications either in the short or medium term.</p><p><strong>Results: </strong>54 Female and 32 male patients were included with a mean age of 43 years (25-64), preoperative body mass index of 42 kg/m<sup>2</sup> (35-49), and preoperative weight of 114 kg (86-162). Thirty-four patients presented with type 2 diabetes (39.5%), 42 patients (49%) diagnosed with hypertension, 24 presented with OSAS (28%), and 21 (24%) hypercholesterolaemia patients were included. In total, 36 patients were diagnosed with multiple comorbidities. The operative data showed an average operative time of 48 minutes with 3.4% of patients suffering from early (minor) complications and 2.3% with a late (minor) complication. One patient required reoperation due to intra-abdominal bleeding. The median length of hospital stay was 2.5 days. Median follow-up was 18 months (5-36). In that period, no patient required ring removal or conversion to Roux-en-Y gastric bypass surgery. Food intolerance/vomiting was present in 1 patient (1.1%), bile reflux was present in 1 patient (1.1%), and no stomal ulcers were observed. Mean % excess weight loss at 12 and 24 months was 72% and 80%, respectively. Fifty-two out of 86 patients (60%) had a complete resolution of comorbidities. A CONUT score >2 (mild malnutrition) was found in 40% of patients, while a CONUT score 0-1 was found in 60% of patients.</p><p><strong>Conclusion: </strong>LBOAGB shows promising results in terms of safety and efficacy in the short term. Further prospective studies will be required to evaluate the consistency of the results in the long term.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2022-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39898221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Obesity, Adipose Tissue, and Inflammation Answered in Questions. 肥胖、脂肪组织和炎症问题解答。
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-01-22 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2252516
Vanessa A Guerreiro, Davide Carvalho, Paula Freitas

Background. Obesity is a global health problem of epidemic proportions, which is characterized by increased adipose tissue (AT) mass and significant repercussions in different body apparati and systems. AT is a special connective tissue, which contains several types of cells, in addition to adipocytes, and is a highly active endocrine and immune organ, which directly modulates many processes, including energy balance, metabolism, and inflammation. Summary. In this paper, the authors list and attempt to answer in a brief and simple way several questions regarding the complex relationships between obesity, adipose tissue, and inflammation, with the objective to provide an easy way to understand the main changes that occur in this pathological state. The questions are the following: Is adipose tissue only made up of adipocytes? Are adipocytes just a reservoir of free fatty acids? Do different types of fatty tissue exist? If so, which types? Can we further subcategorize the types of adipose tissue? Is it possible to form new adipocytes during adulthood? What is the role of inflammation? What is the role of macrophages? Are macrophages central mediators of obesity-induced adipose tissue inflammation and insulin resistance? What causes macrophage infiltration into adipose tissue? What is the role of hypoxia in AT alterations? Is there cross talk between adipocytes and immune cells? What other changes occur in AT in obesity? Does metabolically healthy obesity really exist? Is this a benign condition? Key messages. Obesity is a complex disease with numerous metabolic consequences, which are mainly the result of dysfunction that occurs in the adipose tissue of patients with this pathology. Understanding the pathophysiology of AT and the changes that occur in obesity would contribute to a better approach to patients with obesity, with the inherent medical implications that could result from this.

背景。肥胖症是一个全球性的流行性健康问题,其特征是脂肪组织(AT)质量增加,并对不同的身体器官和系统产生重大影响。脂肪组织是一种特殊的结缔组织,除脂肪细胞外,还含有多种类型的细胞,是一个高度活跃的内分泌和免疫器官,可直接调节能量平衡、新陈代谢和炎症等许多过程。摘要在本文中,作者列举并试图以简明扼要的方式回答有关肥胖、脂肪组织和炎症之间复杂关系的几个问题,目的是提供一种简便的方法来理解这种病理状态下发生的主要变化。这些问题如下脂肪组织仅仅是由脂肪细胞组成的吗?脂肪细胞只是游离脂肪酸的储存库吗?是否存在不同类型的脂肪组织?如果有,是哪些类型?我们能否进一步细分脂肪组织的类型?成年后有可能形成新的脂肪细胞吗?炎症的作用是什么?巨噬细胞的作用是什么?巨噬细胞是肥胖引发的脂肪组织炎症和胰岛素抵抗的核心介质吗?巨噬细胞浸润脂肪组织的原因是什么?缺氧在 AT 改变中的作用是什么?脂肪细胞和免疫细胞之间是否存在交叉对话?肥胖症患者的血管内皮细胞还发生了哪些变化?代谢健康的肥胖症真的存在吗?这是一种良性疾病吗?关键信息。肥胖症是一种复杂的疾病,会导致多种代谢后果,而这些后果主要是肥胖症患者脂肪组织功能紊乱的结果。了解肥胖症的病理生理学和肥胖症发生的变化有助于更好地治疗肥胖症患者,并由此产生内在的医学影响。
{"title":"Obesity, Adipose Tissue, and Inflammation Answered in Questions.","authors":"Vanessa A Guerreiro, Davide Carvalho, Paula Freitas","doi":"10.1155/2022/2252516","DOIUrl":"10.1155/2022/2252516","url":null,"abstract":"<p><p><i>Background</i>. Obesity is a global health problem of epidemic proportions, which is characterized by increased adipose tissue (AT) mass and significant repercussions in different body apparati and systems. AT is a special connective tissue, which contains several types of cells, in addition to adipocytes, and is a highly active endocrine and immune organ, which directly modulates many processes, including energy balance, metabolism, and inflammation. <i>Summary</i>. In this paper, the authors list and attempt to answer in a brief and simple way several questions regarding the complex relationships between obesity, adipose tissue, and inflammation, with the objective to provide an easy way to understand the main changes that occur in this pathological state. The questions are the following: Is adipose tissue only made up of adipocytes? Are adipocytes just a reservoir of free fatty acids? Do different types of fatty tissue exist? If so, which types? Can we further subcategorize the types of adipose tissue? Is it possible to form new adipocytes during adulthood? What is the role of inflammation? What is the role of macrophages? Are macrophages central mediators of obesity-induced adipose tissue inflammation and insulin resistance? What causes macrophage infiltration into adipose tissue? What is the role of hypoxia in AT alterations? Is there cross talk between adipocytes and immune cells? What other changes occur in AT in obesity? Does metabolically healthy obesity really exist? Is this a benign condition? <i>Key messages</i>. Obesity is a complex disease with numerous metabolic consequences, which are mainly the result of dysfunction that occurs in the adipose tissue of patients with this pathology. Understanding the pathophysiology of AT and the changes that occur in obesity would contribute to a better approach to patients with obesity, with the inherent medical implications that could result from this.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2022-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938152/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40317492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case-Control Study of the Association of Leptin Gene Polymorphisms with Plasma Leptin Levels and Obesity in the Kerala Population. 喀拉拉邦人群瘦素基因多态性与血浆瘦素水平和肥胖关系的病例对照研究
IF 3.3 Q1 Medicine Pub Date : 2022-01-01 DOI: 10.1155/2022/1040650
Sudharmadevi K Manju, Thottathil R Anilkumar, G Vysakh, Balakumaran K Leena, Vijayalekshmi Lekshminarayan, Pradeep G Kumar, Trivikrama K Shenoy

Background: Over the last few years, the importance of leptin in energy metabolism has been extensively studied in both animal models and in humans. Very few results are available on the association between human leptin gene (LEP) variants and obesity traits in India. We designed this study to analyse the polymorphisms in human leptin gene and the association of sequence variants with obesity among the population in Kerala, South India.

Methods: In this case-control design of 148 study participants, data were collected on socioeconomic aspects and anthropometric measurements. Plasma glucose, insulin, leptin, and lipid profile were measured. Genotyping was done by automated DNA sequencing.

Results: The common Single Nucleotide Polymorphism (SNP) of 5'-UTR of LEP - 2548G/A was found to be present in the study population with "A" variant as dominant allele. A novel synonymous mutation Thr5Thr of exon 2 of LEP was identified in heterozygous form in one subject with morbid obesity with hyperleptinemia. A novel missense mutation Phe17Leu was observed in two subjects with obesity in heterozygous condition. A novel missense mutation Lys36Arg in exon 2 of LEP was observed in one subject with abdominal obesity and decreased serum leptin level.

Conclusion: LEP - 2548G/A at 5'-untranslated region was found to be common with the mutant "A" variant in the study population. SNPs of exons in LEP were found to be rare but associated with morbid obesity and altered levels of serum leptin in the study population in Kerala, India.

背景:在过去的几年里,瘦素在能量代谢中的重要性已经在动物模型和人类中得到了广泛的研究。在印度,很少有关于人类瘦素基因(LEP)变异与肥胖特征之间关系的结果。本研究旨在分析印度南部喀拉拉邦人群瘦素基因多态性及其序列变异与肥胖的关系。方法:在148名研究参与者的病例对照设计中,收集了社会经济方面和人体测量的数据。测定血糖、胰岛素、瘦素和血脂。通过自动DNA测序进行基因分型。结果:LEP - 2548G/A的5′- utr共有单核苷酸多态性(SNP)存在于以“A”变异体为优势等位基因的研究人群中。LEP外显子2的一个新的同义突变Thr5Thr在一名患有病态肥胖和高瘦素血症的受试者中以杂合形式被鉴定出来。在2例肥胖患者杂合状态下发现了一种新的错义突变Phe17Leu。在一名腹部肥胖和血清瘦素水平下降的受试者中,观察到LEP外显子2中新错义突变Lys36Arg。结论:LEP - 2548G/A在研究人群的5′-非翻译区与突变体“A”共同存在。在印度喀拉拉邦的研究人群中,LEP外显子的snp被发现是罕见的,但与病态肥胖和血清瘦素水平改变有关。
{"title":"A Case-Control Study of the Association of Leptin Gene Polymorphisms with Plasma Leptin Levels and Obesity in the Kerala Population.","authors":"Sudharmadevi K Manju,&nbsp;Thottathil R Anilkumar,&nbsp;G Vysakh,&nbsp;Balakumaran K Leena,&nbsp;Vijayalekshmi Lekshminarayan,&nbsp;Pradeep G Kumar,&nbsp;Trivikrama K Shenoy","doi":"10.1155/2022/1040650","DOIUrl":"https://doi.org/10.1155/2022/1040650","url":null,"abstract":"<p><strong>Background: </strong>Over the last few years, the importance of leptin in energy metabolism has been extensively studied in both animal models and in humans. Very few results are available on the association between human leptin gene (<i>LEP</i>) variants and obesity traits in India. We designed this study to analyse the polymorphisms in human leptin gene and the association of sequence variants with obesity among the population in Kerala, South India.</p><p><strong>Methods: </strong>In this case-control design of 148 study participants, data were collected on socioeconomic aspects and anthropometric measurements. Plasma glucose, insulin, leptin, and lipid profile were measured. Genotyping was done by automated DNA sequencing.</p><p><strong>Results: </strong>The common Single Nucleotide Polymorphism (SNP) of 5'-UTR of <i>LEP</i> - 2548G/A was found to be present in the study population with \"A\" variant as dominant allele. A novel synonymous mutation Thr5Thr of exon 2 of <i>LEP</i> was identified in heterozygous form in one subject with morbid obesity with hyperleptinemia. A novel missense mutation Phe17Leu was observed in two subjects with obesity in heterozygous condition. A novel missense mutation Lys36Arg in exon 2 of <i>LEP</i> was observed in one subject with abdominal obesity and decreased serum leptin level.</p><p><strong>Conclusion: </strong><i>LEP</i> - 2548G/A at 5'-untranslated region was found to be common with the mutant \"A\" variant in the study population. SNPs of exons in <i>LEP</i> were found to be rare but associated with morbid obesity and altered levels of serum leptin in the study population in Kerala, India.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10538859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Retracted: Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study. 撤回:英国生物库研究中的肥胖测量和SARS-CoV-2检测阳性的风险。
IF 3.3 Q1 Medicine Pub Date : 2022-01-01 DOI: 10.1155/2022/9848453
Journal Of Obesity

[This retracts the article DOI: 10.1155/2021/8837319.].

[本文撤回文章DOI: 10.1155/2021/8837319.]。
{"title":"Retracted: Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study.","authors":"Journal Of Obesity","doi":"10.1155/2022/9848453","DOIUrl":"https://doi.org/10.1155/2022/9848453","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2021/8837319.].</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9904113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Obesity
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1